February, marked globally as Cancer Prevention Month, is a time to renew our commitment to reducing the impact of cancer. This month serves as a reminder of the significant strides made in cancer research, treatment, and prevention. However, it also underscores the need for continued vigilance and...

Learn about the symptoms, treatments, and management of the most common types of blood cancer. Key takeaways: Blood cancer has three common forms Various medical procedures are available to treat these forms of the disease Early detection can make treatments more effective Over 1.3 million...

  Few prescriptions can be called cheap, but some drug expenses are stratospheric. Here are the nation’s most expensive drugs. Here’s a fact that’s hard to swallow: U.S. prescription drug prices are more than twice as expensive as those in other developed countries,...

Cancer medication Blincyto (blinatumomab) has received accelerated approval as a treatment to reduce the risk of relapse in certain patients with B-cell precursor acute lymphoblastic leukemia (ALL). Under the latest US Food and Drug Administration (FDA) approval, Blincyto is indicated for adults...

Adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) have a new targeted treatment option, following the US Food and Drug Administration's (FDA) approval of Besponsa (inotuzumab ozogamicin). The drug, developed by Pfizer, was granted Priority Review,...